A detailed history of Caitong International Asset Management Co., LTD transactions in Vericel Corp stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 17 shares of VCEL stock, worth $705. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17
Holding current value
$705
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$44.5 - $61.8 $756 - $1,050
17 New
17 $759,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $1.96B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Caitong International Asset Management Co., LTD Portfolio

Follow Caitong International Asset Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitong International Asset Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Caitong International Asset Management Co., LTD with notifications on news.